With ExAblate(R), the physician uses the Magnetic Resonance Imaging (MRI) with registered CT images to visualize the patient's anatomy and then aims focused ultrasound waves at the tumor to relieve the pain. The MRI allows the physician to monitor and continuously adjust the treatment in real time. The patient is consciously sedated to alleviate pain and minimize motion. Due to the high acoustic absorption and low thermal conductivity of the bone cortex, it is possible to use a low level of energy and still achieve a localized heating effect that will relieve the pain while minimizing damage to adjacent tissue.
Participating sites include Brigham & Women's Hospital in Boston, Fox
Chase Cancer Center in Philadelphia, Houston Methodist in Houston, Texas,
SightLine Medical Center, Houston, Texas, the Lahey Clinic in Burlington,
Additional information on the trial, including contact information for the clinical coordinators at each of the sites, can also be viewed at the National Institutes of Health's website, http://www.clinicaltrials.gov/ct2/show/NCT00656305?term=bone+metastases+insig htec&rank=1.
(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)
Media Contact: Hollister Hovey Lazar Partners Ltd. firstname.lastname@example.org
|SOURCE InSightec Ltd|
Copyright©2008 PR Newswire.
All rights reserved